ADIA Provides Advice On Government Research Priorities
28th Jun 18
Australia’s dental industry has been asked to provide advice to the Australian Government on the development of the second set of 2018-20 Medical Research Future Fund (MRFF) grant priorities.
Key Issues For The Dental Industry —
The Medical Research Future Fund is a $20 billion Australian Government initiative that supercharges the growth in cutting-edge health and medical research. The objective is to support development of new cures and treatments that are improving health outcomes across Australia while fuelling jobs, economic growth and export potential.
Consistent with the Medical Research Future Fund Act 2015 (Cth), the independent Australian Medical Research Advisory Board (AMRAB) is conducting a national consultation to inform the development of the second set of 2018-2020 MRFF Australian Medical Research and Innovation Priorities. ADIA has been invited to provide advice to the Australian Government on the priorities.
Using the advice and guidance from members serving on the ADIA-MIG Manufacturers Interest Group, the advice from the dental industry will help inform Australian Government decisions on MRFF funding priorities.
The MRFF has already committed $65.9million in the 2017-18 Australian Government Budget to fund eight commitments over four years. The 2018-19 Australian Government Budget provided a further $1,651.7 billion over five to ten years to expand funding to include eleven new initiatives. This includes the National Health and Medical Industry Growth Plan which captures $1.2 billion of MRFF funding.
Member Engagement —
Members serving on the ADIA-MIG Manufacturers Interest Group provide advice and guidance to the ADIA policy advocacy team on matters associated with Australian Government funding for dental product research, development, commercialisation, manufacturing and exports. Quarterly updates are available to members at the quarterly ADIA State Branch Briefing series.
Further Information —
To keep up to date with matters associated with dental product regulation subscribe to the Twitter feed @AusDental or follow us on Facebook at www.facebook.com/dental.industry. Alternatively, you can contact the Association via email at email@example.com or by telephone on 1300 943 094.
Currency Of Information & Disclaimer —
This update was issued on 27 June 2018 and please note that changes in circumstances after the publication of material or information may impact upon its accuracy and also change regulatory compliance obligations. The statements, regulatory and technical information contained herein are believed to be accurate and are provided for information purposes only. Readers are responsible for assessing its relevance and verifying the accuracy of the content. To the fullest extent permitted by law, ADIA will not be liable for any loss, damage, cost or expense incurred in relation to or arising as a result of relying on the information presented here.
This publication is available for your use under a Creative Commons Attribution 3.0 Australia licence, with the exception of the ADIA logo, images and where stated.
|A —.. A D I A . .S T R A T G E G I C . .A L L I A N C E S
10th Apr 18
In the next step towards ratification of and important free trade agreement that will support the dental industry, the TPP-11 agreement was presented to the Australian Parliament where it will undergo parliamentary committee scrutiny.
24th Jan 18
Proposed legislative amendments that provide the Therapeutic Goods Administration (TGA) with stronger compliance and enforcement powers and graduated penalties for non-compliant behaviours has been endorsed by the dental industry.